- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07615920
HILT vs ESWT in Supraspinatus Tendinitis
25 de mayo de 2026 actualizado por: sami abdu akkur, Kafrelsheikh University
Comparative Effectiveness of High-Intensity Laser Therapy Versus Extracorporeal Shock Wave Therapy in Patients With Supraspinatus Tendinitis
This randomized controlled trial aims to compare the effectiveness of High-Intensity Laser Therapy (HILT) and Extracorporeal Shock Wave Therapy (ESWT) in patients with supraspinatus tendinitis.
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Tipo de estudio
Intervencionista
Inscripción (Estimado)
48
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: SAMI ABDU AKKUR, MASTER
- Número de teléfono: +966500433558
- Correo electrónico: pt.sami558@gmail.com
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria:
- Male and female participants aged between 18 and 60 years.
- Clinically diagnosed supraspinatus tendinitis confirmed by ultrasound imaging.
- Shoulder pain duration greater than 3 months.
- Ability to understand and follow study instructions.
- Willingness to participate and provide informed consent.
Exclusion Criteria:
- Full-thickness rotator cuff tear.
- Previous shoulder surgery.
- Pregnancy.
- Neurological disorders affecting the upper limb.
- Corticosteroid injection within the previous 3 months.
- Shoulder fracture or dislocation.
- Systemic inflammatory diseases.
- Participation in other physical therapy programs during the study period
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Group A: HILT + Conventional PT
|
High-Intensity Laser Therapy (HILT) is an advanced electrotherapy modality that uses high-power laser energy to penetrate deep musculoskeletal tissues and stimulate biological healing processes.
The device emits laser wavelengths ranging between 808-1064 nm with high peak power output, allowing deeper tissue penetration compared to conventional low-level laser therapy.
HILT provides analgesic, anti-inflammatory, and biostimulatory effects through increasing local blood circulation, enhancing cellular metabolism, stimulating collagen synthesis, and promoting tissue regeneration.
The treatment is non-invasive, safe, and commonly used in musculoskeletal rehabilitation, particularly for tendinopathies and chronic pain conditions.
The conventional physical therapy program consisted of a combination of therapeutic exercises and physical therapy modalities aimed at reducing pain, improving shoulder range of motion, enhancing muscle strength, and restoring functional performance.
The program included hot pack application, Transcutaneous Electrical Nerve Stimulation (TENS), stretching exercises, range of motion exercises, strengthening exercises for the rotator cuff and scapular stabilizers, as well as a home exercise program.
Treatment sessions were conducted three times per week according to the patient's tolerance and clinical condition
|
|
Comparador activo: Group B: ESWT + Conventional PT
|
The conventional physical therapy program consisted of a combination of therapeutic exercises and physical therapy modalities aimed at reducing pain, improving shoulder range of motion, enhancing muscle strength, and restoring functional performance.
The program included hot pack application, Transcutaneous Electrical Nerve Stimulation (TENS), stretching exercises, range of motion exercises, strengthening exercises for the rotator cuff and scapular stabilizers, as well as a home exercise program.
Treatment sessions were conducted three times per week according to the patient's tolerance and clinical condition
Extracorporeal Shock Wave Therapy (ESWT) is a non-invasive therapeutic modality that delivers high-energy acoustic waves to injured musculoskeletal tissues.
The device generates focused or radial shock waves that stimulate tissue healing, neovascularization, pain reduction, and cellular repair mechanisms.
ESWT is widely used in the management of tendinopathies, calcific disorders, and chronic musculoskeletal pain.
Treatment parameters typically include energy flux density, frequency, number of impulses, and treatment sessions.
The therapy is considered safe and effective, with minimal side effects
|
|
Comparador activo: Group C: Conventional Physical Therapy Only
|
The conventional physical therapy program consisted of a combination of therapeutic exercises and physical therapy modalities aimed at reducing pain, improving shoulder range of motion, enhancing muscle strength, and restoring functional performance.
The program included hot pack application, Transcutaneous Electrical Nerve Stimulation (TENS), stretching exercises, range of motion exercises, strengthening exercises for the rotator cuff and scapular stabilizers, as well as a home exercise program.
Treatment sessions were conducted three times per week according to the patient's tolerance and clinical condition
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Pain intensity measured using Visual Analogue Scale (VAS).
Periodo de tiempo: At baseline and immediately after 4 weeks of intervention
|
Pain intensity will be assessed using the Visual Analogue Scale (VAS), where 0 indicates no pain and 10 indicates worst imaginable pain.
|
At baseline and immediately after 4 weeks of intervention
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Shoulder Pain and Disability Measured by the Shoulder Pain and Disability Index (SPADI)
Periodo de tiempo: At baseline and immediately after 4 weeks of intervention
|
Shoulder pain and disability will be assessed using the Shoulder Pain and Disability Index (SPADI).
The SPADI score ranges from 0 to 100, with higher scores indicating greater pain and disability.
|
At baseline and immediately after 4 weeks of intervention
|
|
Upper Extremity Function Measured by the Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH)
Periodo de tiempo: Time Frame: Baseline and immediately after 4 weeks of intervention.
|
Upper extremity function will be assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire.
DASH scores range from 0 to 100, with higher scores indicating greater disability.
|
Time Frame: Baseline and immediately after 4 weeks of intervention.
|
|
Shoulder Range of Motion Measured Using a Digital Goniometer
Periodo de tiempo: Baseline and immediately after 4 weeks of intervention.
|
Shoulder range of motion (flexion, abduction, and external rotation) will be measured in degrees using a digital goniometer.
Higher values indicate greater shoulder mobility.
|
Baseline and immediately after 4 weeks of intervention.
|
|
Quality of Life Measured by the Short Form-36 Health Survey (SF-36)
Periodo de tiempo: Baseline and immediately after 4 weeks of intervention.
|
Quality of life will be assessed using the Short Form-36 Health Survey (SF-36).
Scores range from 0 to 100, with higher scores indicating better health-related quality of life.
|
Baseline and immediately after 4 weeks of intervention.
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Director de estudio: Yasmin Mohamed Mahmoud, Kafrelsheikh University Faculty of Physical Therapy Department of Basic Sciences for Physical Therapy
- Silla de estudio: Mahmoud Mohamed Ewida, PHD, Kafrelsheikh University Faculty of Physical Therapy Department of Basic Sciences for Physical Therapy
- Director de estudio: Shaimaa Ramadan Eldeab, PHD, Kafrelsheikh University Faculty of Physical Therapy Department of Basic Sciences for Physical Therapy
- Investigador principal: Sami ABDU Akkur, MASTER DEGREE STUDENT, Kafrelsheikh University Faculty of Physical Therapy Department of Basic Sciences for Physical Therapy
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
1 de agosto de 2026
Finalización primaria (Estimado)
30 de octubre de 2026
Finalización del estudio (Estimado)
30 de diciembre de 2027
Fechas de registro del estudio
Enviado por primera vez
19 de mayo de 2026
Primero enviado que cumplió con los criterios de control de calidad
25 de mayo de 2026
Publicado por primera vez (Actual)
29 de mayo de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
29 de mayo de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
25 de mayo de 2026
Última verificación
1 de mayo de 2026
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- KFSIRB200-1036
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
INDECISO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .